Clinical Trials Logo

Clinical Trial Summary

We hypothesize that the perioperative administration of pregabalin will significantly decrease pain scores and post-operative opioid requirements for patients undergoing coronary artery bypass grafting, and reduces the incidence of opioid-induced side effects such as respiratory depression. This may reduce ICU admission and possibly abbreviate length of hospital stay.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00623285
Study type Interventional
Source University of Manitoba
Contact Joel A Loiselle, MD
Phone 204-237-2580
Email jloiselle@sbgh.mb.ca
Status Recruiting
Phase Phase 3
Start date April 2008
Completion date June 2011